NovoCure Limited (NVCR)
(Delayed Data from NSDQ)
$23.35 USD
+2.55 (12.24%)
Updated Jul 30, 2024 04:00 PM ET
After-Market: $22.83 -0.52 (-2.21%) 7:50 PM ET
2-Buy of 5 2
D Value B Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/24/2024
Time: -- |
9/2024 | $-0.36 | 5.91% |
Earnings Summary
For their last quarter, NovoCure Limited (NVCR) reported earnings of -$0.31 per share, beating the Zacks Consensus Estimate of $-0.40 per share. This reflects a positive earnings surprise of 22.50%. Look out for NVCR's next earnings release expected on October 24, 2024. For the next earning release, we expect the company to report earnings of -$0.36 per share, reflecting a year-over-year increase of 21.74%.
Earnings History
Price & Consensus
Zacks News for NVCR
NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates
NVCR: What are Zacks experts saying now?
Zacks Private Portfolio Services